TITLE

Infective Endocarditis Complicating Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infection

AUTHOR(S)
Sohail, Muhammad R.; Uslan, Daniel Z.; Khan, Akbar H.; Friedman, Paul A.; Hayes, David L.; Wilson, Walter R.; Steckelberg, James M.; Jenkins, Sarah M.; Baddour, Larry M.
PUB. DATE
January 2008
SOURCE
Mayo Clinic Proceedings;Jan2008, Vol. 83 Issue 1, p46
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To describe management of patients with permanent pacemaker (PPM)- and implantable cardioverter-defibrillator (ICD)-related endocarditis. PATIENTS AND METHODS: We retrospectively reviewed all cases of Infection involving PPMs and ICDs among patients presenting to Mayo Clinic's site in Rochester, MN, between January 1, 1991, and December 31, 2003. Cardiac device-related infective endocarditis (CDIE) was defined as the presence of both vegetation on a device lead or valve and clinical or microbiological evidence of CDIE. Of 189 patients with PPM or lCD infection who were admitted during the study period, 44 met the case definition for CDIE (33 PPM, 11 lCD). RESULTS: The mean ± SD age of patients was 67±14 years. Staphylococci (36 [82%]) were the most commonly isolated pathogens. Nearly all patients (43 [98%]) were treated with a combined approach of complete hardware removal and parenteral antibiotics. The median duration of antibiotic treatment after infected device explantation was 28 days (interquartile range, 19- 42 days). Device leads were removed percutaneously in 34 cases (77%); only 7 cases (16%) required surgical lead extraction. Percutaneous extraction was uncomplicated in 15 patients with lead vegetation greater than 10 mm in diameter. Six patients (14%) died during hospitalization. Twenty-seven (96%) of 28 patients remained infection free at their last visit (median follow-up, 183 days; intraquartile range, 36-628 days). CONCLUSION: Prompt hardware removal and prolonged parenteral antibiotic administration decrease mortality among patients with CDIE. The presence of a large (>10 mm in diameter) vegetation on a lead is not a contraindication for percutaneous lead extraction.
ACCESSION #
28095604

 

Related Articles

  • Current aspects of infective endocarditis. Mansi, Ishak A.; Carden, Donna // Patient Care for the Nurse Practitioner;Jun2004, Vol. 7 Issue 6, p3 

    The article provides information on infective endocarditis (IE). The mean age of patients with native valve endocarditis increased from 35 years in the preantibiotic era to a current mean age of 54 years. The pathogens of IE have changed because of surges in cases due to Staphylococcus aureus...

  • Current aspects of infective endocarditis. Mansi, Ishak A.; Carden, Donna // Patient Care;Jun2004, Vol. 38 Issue 6, p38 

    Provides information on components that raise suspicion of infective endocarditis (IE) in febrile patients. Factors that caused changes in the pathogens of IE; Cardiac complications of IE; Pathogenesis and microbiology of IE. INSET: Pathogenesis and microbiology of IE.

  • Commentary on endocarditis prophylaxis: a quaint custom or medical necessity? Prendergast, B. D.; Harrison, J. I.; Naber3, C. K. // Heart;Jul2008, Vol. 94 Issue 7, p931 

    The article comments on issues relating to endocarditis prophylaxis. It reveals that infective endocarditis (IE) is an elusive condition which continues to challenge all those involved in its investigation and management. The article discusses the changes in the demography of IE with increasing...

  • Early Surgery vs. Antibiotics for Infectious Endocarditis. Zepf, Bill // American Family Physician;3/15/2002, Vol. 65 Issue 6, p1208 

    Presents information on a study by J. Bishara and others on the long-term survival impact of early surgical intervention to remove the infected valve compared with standard antibiotic therapy alone for treatment of infectious endocarditis. Description of the study and its results; Conclusion...

  • Endocarditis at the Millennium. Hoesley, Craig J.; Cobbs, C. Glenn // Journal of Infectious Diseases;3/15/99 Supplement 2, Vol. 179, pS360 

    Focuses on the demographics, diagnostic methods and therapeutic options for the management of infective endocarditis (IE). Contributions of the members of the Interplanetary Society to the understanding of the pathogenesis of IE; Atypical pathogens causing IE; Provision of effective...

  • Antibiotic Treatment in Native Valve Infective Endocarditis. Garc�a-Borbolla, Rafael; Garc�a-Borbolla, Mariano // Infectious Disorders - Drug Targets;Feb2010, Vol. 10 Issue 1, p47 

    Previous to the availability of antimicrobial therapy, infective endocarditis (IE) was habitually lethal. Although approximately 80 percent of patients with endocarditis currently survive their infections, one of every six patients with IE does not survive the initial hospitalization, and up to...

  • ANTIBIOTIC PROPHYLAXIS FOR INFECTIVE ENDOCARDITIS: ETHICAL CARE IN THE ERA OF REVISED GUIDELINES. Bach, David S. // Methodist DeBakey Cardiovascular Journal;Dec2010, Vol. 6 Issue 4, p48 

    The article examines the arguments for and against antibiotic prophylaxis and also discusses why the revised guidelines are likely to fail to respect the ethical principles of beneficence and patient autonomy. A large randomized controlled trial has not been conducted to test the role of...

  • Intravenous Followed by Oral Antimicrobial Therapy for Staphylococcal Endocarditis. PARKER, RICHARD H.; FOSSIECK, Jr., BYRON E. // Annals of Internal Medicine;Dec80, Vol. 93 Issue 6, p832 

    We have treated 35 cases of staphylococcal endocarditis in 33 patients with intravenous followed by oral antimicrobial therapy. All patients had three or more blood cultures positive for Staphylococcus aureus, and all had cardiac murmurs characteristic of valvular insufficiency. The mean total...

  • Clinafloxacin for the Treatment of Bacterial Endocarditis. Levine, Donald P.; Holley, H. Preston; Eiseman, Irene; Willcox, Paul; Tack, Kenneth // Clinical Infectious Diseases;3/1/2004, Vol. 38 Issue 5, p620 

    We report the results of a prospective, multicenter trial assessing intravenous and oral clinafloxacin treatment for infective endocarditis. Sixty-six patients constituted the final study population. Among the 53 patients with native valve infection, Staphylococcus aureus and Streptococcus...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics